Tag Archives: pharmaceutical industry

Why California’s Proposition 61 Was a Bad Idea

New approaches to control state pharmaceutical costs are needed.1 This issue is particularly critical in California, the state with the largest pharmaceutical expenditures in the country.1 A controversial California ballot initiative aimed at reining in prescription drug expenditures was defeated on November 8, 2016 by a 54% to 46% margin.2The California Drug Price Relief Act, also known […]

Read more
white, male doctor smiling

Author Self-disclosure Compared with Pharmaceutical Company Reporting of Physician Payments

Caution is advised in the interpretation of Sunshine Act data and accuracy of guideline authors’ relationships with industry. Background Industry manufacturers are required by the Sunshine Act to disclose payments to physicians. These data recently became publicly available, but some manufacturers prereleased their data since 2009. We tested the hypotheses that there would be discrepancies […]

Read more

Reflections on the Physicians Payment Sunshine Act

Society has clearly benefited from the partnership between the pharmaceutical and medical device industries. For more than 100 years there has been an unwritten understanding that industry, working in a market economy, would develop those treatments that physicians and their patients require, while the government would supervise the approval process, as well as regulate the […]

Read more

UA-42320404-1